Latest Conference Coverage

Blue Fin Group executive highlights how leaders can plan for immediate profitable lifecycles and beyond.

SVP and Managing Director for Blue Fin Group offers a synopsis of the conference opener.

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Conference presentation explores groundbreaking topics impacting the pharma industry.

Director of Berkeley Research Group explains changes to 340B moving forward.

Berkeley Research Group executive speaks about the role of manufacturers in 340B pricing.

Berkeley Research Group Director discusses what to expect at his upcoming session.

Session explores how on-market products have done, and what to expect from new biosimilars.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.

Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.

LogiPharma session reminds attendees of what to review, as far as DSCSA compliance is concerned.

A panel at the recent Talk Health event in Philadelphia focused on what success looks like in audio from publisher, vendor, and HCP perspectives.

Stakeholders uncover the obstacles surrounding the industry onboarding process.

Attendees meet to discuss operational issues related to traceability implementation.

Session offers information on industry readiness, plus an overview of a phase implementation recommendation.

Pharma Commerce provides a summary of conference breakout session.

Event’s first session aims to analyze the legislation’s implementation, as FDA enforcement is delayed until November 2024.

In an interview at the DIA Global Annual Meeting with Pharma Commerce Editor, Nicholas Saraceno, Venkatraman Balasubramanian discusses broader supply chain issues.

Panel explores challenges that could affect their development.

In an interview with Pharma Commerce Editor, Nicholas Saraceno, Courtney Granville, Director, Scientific Affairs, Drug Information Association, discusses issues impacting broader supply chains.

Session offers a look into the Inflation Reduction Act’s impact on market conditions.

Session explores practicality of models for selling low-cost drugs.

In an interview at the DIA Global Annual Meeting with Pharma Commerce Editor, Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses SMART on FHIR and supply chains.

Roundtable drills down on ways the two sectors can come together to reduce carbon emissions.